![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
UDG Healthcare plc, a leading international healthcare services provider, has appointed Ryan Quigley as Chief Operating Officer (COO).
Based in UDG’s headquarters in Dublin, Ireland, Ryan will join the UDG Senior Executive Team and take responsibility for establishing and delivering long term strategic growth plans for the organisation’s Ashfield and Sharp divisions.
Ryan has over 25 years’ experience in a variety of leadership roles across the pharmaceutical sector, working for some of the most well-renowned names in the industry such as AbbVie, Pfizer and Bristol Myers Squibb.
Brendan McAtamney, CEO at UDG Healthcare plc said: “During our strategic planning process, we identified many opportunities for our Ashfield and Sharp divisions to work more collaboratively.
“We have exceptional talent and experience across both divisions and so we want to make sure we are strengthening existing partnerships to enable shared insights and resources more effectively, allowing us to provide more and improved services to our customers.
“Ryan’s role will be central to creating the necessary focus to realise these opportunities. I’m incredibly excited to welcome him to the team and to work together towards our goals.”
Ryan has led the commercial operations for many blockbuster brands including a tenure as Vice President, Immunology Global Marketing at AbbVie when HUMIRA® became the best-selling pharmaceutical product. Ryan holds an MBA in business administration and a Bachelor’s degree in environmental health science.
Commenting on his appointment Ryan added: “I am really pleased to be joining such a dynamic and fast-growing organisation. There is exceptional talent at both Ashfield and Sharp, and I am inspired to see the valuable outcomes of the two divisions collaborating more closely for our global client base.”
Ashfield provides strategic consulting, audit, advisory, healthcare communications, field and contact centre sales teams, in-home and contact centre clinical educators, medical information and event management services.
Sharp is a global leader in advanced clinical supply chain services and contract pharmaceutical packaging. Offering solutions and support to pharma and biotech clients from phase I trials all the way through to commercialisation and rapid launch.
About UDG Healthcare plc:
UDG Healthcare plc is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing 8,200 people, operating in 29 countries and delivering services in more than 50 countries.
UDG Healthcare plc operates across two divisions: Ashfield and Sharp.
About Ashfield
Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with our clients across Advisory, Healthcare Communications, Commercial, Patient Solutions and Medical Affairs to build creative, scalable and tailored health solutions that are executed flawlessly, to address our client’s challenges and deliver positive outcomes for patients. With more than 7,200 employees, the company operates in 28 countries, delivering services in more than 50 countries across Europe, North America, South America and Asia. It works with more than 250 businesses, including all of the world’s top 25 pharmaceutical companies.
Its mission is to partner with its clients, helping to improve lives by ensuring healthcare professionals and patients get the medicines, knowledge and support they need.
Ashfield provides strategic consulting, audit, advisory, healthcare communications, field and contact centre sales teams, in-home and contact centre clinical educators, medical information, and event management services.
About Sharp
Sharp, part of UDG healthcare, is a global leader in advanced clinical supply chain services and contract pharmaceutical packaging. Offering solutions and support to pharma and biotech clients from phase I trials all the way through to commercialization and rapid launch. The organisation has state-of-the-art facilities in the United States, United Kingdom, Belgium and the Netherlands and over 32 clinical depots globally, covering every region of the world.
The company offers a full complement of integrated services includes: analytical, formulation development, clinical manufacturing & packaging, clinical IRT, blister packaging, bottling, secondary assembly and labelling of injectable presentations, compliance packaging, as well as storage and distribution. Sharp also offers Qualified Person (QP) services for European distribution.
Through our partnership with Berkshire Sterile Manufacturing, it also offers specialist isolator-based filling of vials, syringes, cartridges and containers, as well as lyophilization and terminal sterilization.
